| Literature DB >> 29893815 |
Marta Noa Valcarcel-Ares1, Zsuzsanna Tucsek1, Tamas Kiss1, Cory B Giles1,2, Stefano Tarantini1, Andriy Yabluchanskiy1, Priya Balasubramanian1, Tripti Gautam1, Veronica Galvan3, Praveen Ballabh4, Arlan Richardson1,5, Willard M Freeman1, Jonathan D Wren1,2, Ferenc Deak1,6, Zoltan Ungvari1,7, Anna Csiszar1,8.
Abstract
There is strong evidence that obesity has deleterious effects on cognitive function of older adults. Previous preclinical studies demonstrate that obesity in aging is associated with a heightened state of systemic inflammation, which exacerbates blood-brain barrier disruption, promoting neuroinflammation and oxidative stress. To test the hypothesis that synergistic effects of obesity and aging on inflammatory processes exert deleterious effects on hippocampal function, young and aged C57BL/6 mice were rendered obese by chronic feeding of a high-fat diet followed by assessment of learning and memory function, measurement of hippocampal long-term potentiation (LTP), assessment of changes in hippocampal expression of genes relevant for synaptic function and determination of synaptic density. Because there is increasing evidence that altered production of lipid mediators modulate LTP, neuroinflammation and neurovascular coupling responses, the effects of obesity on hippocampal levels of relevant eicosanoid mediators were also assessed. We found that aging exacerbates obesity-induced microglia activation, which is associated with deficits in hippocampal-dependent learning and memory tests, impaired LTP, decreased synaptic density, and dysregulation of genes involved in regulation of synaptic plasticity. Obesity in aging also resulted in an altered hippocampal eicosanoid profile, including decreases in vasodilator and pro-LTP epoxy-eicosatrienoic acids (EETs). Collectively, our results taken together with previous findings suggest that obesity in aging promotes hippocampal inflammation, which in turn may contribute to synaptic dysfunction and cognitive impairment.Entities:
Keywords: Inflammaging; Metabolic syndrome; Mild cognitive impairment; VCI; Vascular cognitive impairment
Mesh:
Substances:
Year: 2019 PMID: 29893815 PMCID: PMC6376091 DOI: 10.1093/gerona/gly127
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.053